Journal of the American College of Cardiology

Journal

Publication Venue For

  • Trends in Lipid, Lipoproteins, and Statin Use Among U.S. Adults: Impact of 2013 Cholesterol Guidelines.  74:2525-2528. 2019
  • Improving Communication in Heart Failure Patient Care.  74:1682-1692. 2019
  • Time to Rethink Prevention of Chronic Kidney Disease?.  74:1477-1479. 2019
  • Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.  74:617-627. 2019
  • Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.  73:3054-3063. 2019
  • Effect of Calcium-Channel Blocker Therapy on Radial Artery Grafts After Coronary Bypass Surgery.  73:2299-2306. 2019
  • Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease.  73:2036-2045. 2019
  • Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel.  73:317-335. 2019
  • Differences in Risk of Sudden Cardiac Death Between Blacks and Whites.  72:2431-2439. 2018
  • Do Not Smoke, Eat Healthy, and Exercise .  72:2306-2308. 2018
  • 2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk.  72:1187-1197. 2018
  • Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients.  72:707-717. 2018
  • Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States.  71:1729-1737. 2018
  • Effect of NT-proBNP–Guided Therapy on All-Cause Mortality in Chronic Heart Failure With Reduced Ejection Fraction.  71:951-952. 2018
  • Performance of Coronary Risk Scores Among Patients With Chest Pain in the Emergency Department.  71:606-616. 2018
  • Transplantation of Human Embryonic Stem Cell–Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction.  71:429-438. 2018
  • Trends in Survival After In-Hospital Cardiac Arrest During Nights and Weekends.  71:402-411. 2018
  • Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.  71:109-118. 2018
  • Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.  71:109-118. 2018
  • Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases.  70:2835-2837. 2017
  • Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.  70:1861-1871. 2017
  • Palliative Care in Heart Failure: Rationale, Evidence, and Future Priorities.  70:1919-1930. 2017
  • Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.  70:1875-1886. 2017
  • Submaximal Blood Pressure Responses to Exercise in Young Adulthood and Long-Term Cardiovascular Health.  70:1941-1943. 2017
  • Optimizing Cholesterol Treatment in Patients With Muscle Complaints.  70:1290-1301. 2017
  • Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings.  70:1121-1131. 2017
  • Association of Estimated Sodium Intake With Adverse Cardiac Structure and Function: From the HyperGEN Study..  70:715-724. 2017
  • Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering.  70:766-775. 2017
  • Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014.  69:2696-2706. 2017
  • Reproductive Factors and Incidence of Heart Failure Hospitalization in the Women's Health Initiative.  69:2517-2526. 2017
  • Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment.  69:2446-2456. 2017
  • Reply: Role of Adiponectin: Important or Null?.  69:1518-1519. 2017
  • Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.  69:1386-1395. 2017
  • DESCRIBING COLLABORATION BETWEEN CARDIOLOGY AND PALLIATIVE CARE: A NATIONAL SURVEY STUDY OF CURRENT PRACTICES, CHALLENGES AND BARRIERS.  69:2543-2543. 2017
  • International Recommendations for Electrocardiographic Interpretation in Athletes.  69:1057-1075. 2017
  • Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.  69:679-691. 2017
  • Development of Quality Metrics in Ambulatory Pediatric Cardiology.  69:541-555. 2017
  • Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement.  69:367-377. 2017
  • SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.  69:395-403. 2017
  • The Adipokine-Cardiovascular-Lifestyle Network: Translation to Clinical Practice.  68:1785-1803. 2016
  • Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.  68:985-995. 2016
  • Potential Implications of the Systolic Blood Pressure Intervention Trial in Korea.  67:2832-2834. 2016
  • Ventricular Assist Device in Acute Myocardial Infarction.  67:1871-1880. 2016
  • Acute metabolic influences on the natriuretic peptide system in humans.  67:804-812. 2016
  • U.S. trends in inpatient utilization of fractional flow reserve and percutaneous coronary intervention.  67:732-733. 2016
  • Generalizability of SPRINT Results to the U.S. Adult Population.  67:463-472. 2016
  • Selecting Patients for Statin Therapy in Primary Prevention if We Could only Predict the Future.  66:2710-2712. 2015
  • Enhanced cardiac regenerative ability of stem cells after ischemia-reperfusion injury: Role of human CD34+ cells deficient in microRNA-377.  66:2214-2226. 2015
  • Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011.  66:1864-1872. 2015
  • Heart Failure as a Newly Approved Diagnosis for Cardiac Rehabilitation: Challenges and Opportunities.  65:2652-2659. 2015
  • ACC 2015 Core Cardiovascular Training Statement (COCATS 4) (Revision of COCATS 3): A Report of the ACC Competency Management Committee.  65:1721-1723. 2015
  • 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension the SYMPLICITY HTN-3 trial.  65:1314-1321. 2015
  • COCATS 4 task force 2: Training in preventive cardiovascular medicine.  65:1754-1762. 2015
  • Comprehensive cardiovascular risk factor control improves survival: The BARI 2D trial.  66:765-773. 2015
  • Short-term mechanical circulatory support: The problem of the uninsured.  65:1062-1063. 2015
  • Systems Genomics Identifies a Key Role for Hypocretin/Orexin Receptor-2 in Human Heart Failure.  66:2522-2533. 2015
  • The Gaps in Cardiac Rehabilitation Referral: The Elephant in the Room.  66:2574. 2015
  • The Role of the Clinical Pharmacist in the Care of Patients with Cardiovascular Disease.  66:2129-2139. 2015
  • Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.  65:1998-2038. 2015
  • Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.  65:270-277. 2015
  • Paroxysmal AF catheter ablation with a contact force sensing catheter: Results of the prospective, multicenter SMART-AF trial.  64:647-656. 2014
  • Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: Results from the REGARDS Study (REasons for Geographic and Racial Differences in Stroke).  63:1626-1633. 2014
  • SKELETAL MUSCLE MITOCHONDRIAL FUNCTION AND INTERMITTENT CLAUDICATION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE FOLLOWING SUPERVISED TREADMILL TRAINING.  63:A2074-A2074. 2014
  • Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: Comprehensive analysis to determine the potential role of mitraclip for this unmet need.  63:185-186. 2014
  • Impact of renal denervation on 24-hour ambulatory blood pressure: Results from SYMPLICITY HTN-3.  64:1071-1078. 2014
  • The incremental risk of noncardiac surgery on adverse cardiac events following coronary stenting.  64:2730-2739. 2014
  • Reply.  61:2113. 2013
  • Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: A report from the BARI 2D trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).  61:1767-1776. 2013
  • Risk factor control for coronary artery disease secondary prevention in large randomized trials.  61:1607-1615. 2013
  • Behavioral mechanisms, elevated depressive symptoms, and the risk for myocardial infarction or death in individuals with coronary heart disease: The regards (reason for geographic and racial differences in stroke) study.  61:622-630. 2013
  • Declining frequency of ischemia detection using stress myocardial perfusion imaging.  61:1066-1068. 2013
  • 6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure.  60:2653-2661. 2012
  • Long-term outcomes of older diabetic patients after percutaneous coronary stenting in the United States: A report from the national cardiovascular data registry, 2004 to 2008.  60:2280-2289. 2012
  • Third universal definition of myocardial infarction..  60:1581-1598. 2012
  • A randomized controlled phase IIb trial of Beta 1-receptor blockade for chronic degenerative mitral regurgitation.  60:833-838. 2012
  • Renal failure following ventricular assist device placement.  59:2220. 2012
  • Evaluation of patients with possible cardiac chest pain: A way out of the jungle.  59:2099-2100. 2012
  • Angiotensin II plays a critical role in alcohol-induced cardiac nitrative damage, cell death, remodeling, and cardiomyopathy in a protein kinase c/nicotinamide adenine dinucleotide phosphate oxidase-dependent manner.  59:1477-1486. 2012
  • Prolongation of QTc and risk of stroke: The regards (REasons for Geographic and Racial Differences in Stroke) study.  59:1460-1467. 2012
  • Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: A report from the national cardiovascular data registry, 2004 to 2008.  59:648-654. 2012
  • Health-related quality of life after carotid stenting versus carotid endarterectomy: Results from CREST (Carotid Revascularization Endarterectomy versus Stenting Trial).  58:1557-1565. 2011
  • ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the American college of cardiology foundation task force on clinical expert consensus documents.  57:2037-2114. 2011
  • Effectiveness-based guidelines for the prevention of cardiovascular disease in women - 2011 Update: A guideline from the American Heart Association.  57:1404-1423. 2011
  • Cardiovascular Magnetic Resonance Imaging of the Raghib Complex.  57:e15. 2011
  • Outcomes of the RESTOR-MV trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve).  56:1984-1993. 2010
  • Lack of Association between the Trp719Arg Polymorphism in Kinesin-Like Protein-6 and Coronary Artery Disease in 19 Case-Control Studies.  56:1552-1563. 2010
  • Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes: A multicenter trial.  56:290-299. 2010
  • Single-photon emission computed tomography myocardial perfusion imaging and the risk of sudden cardiac death in patients with coronary disease and left ventricular ejection fraction >35%.  56:206-214. 2010
  • Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study. Fractional Flow Reserve Versus Angiography in Multivessel Evaluation.  55:2816-2821. 2010
  • Survival After Application of Automatic External Defibrillators Before Arrival of the Emergency Medical System. Evaluation in the Resuscitation Outcomes Consortium Population of 21 Million.  55:1713-1720. 2010
  • Increased Oxidative Stress and Cardiomyocyte Myofibrillar Degeneration in Patients With Chronic Isolated Mitral Regurgitation and Ejection Fraction >60%.  55:671-679. 2010
  • Stress-Only Myocardial Perfusion Imaging. A New Paradigm.  55:231-233. 2010
  • Late Vascular Healing Response to Stents. New Insights From Optical Coherence Tomography.  55:33-34. 2009
  • Menopause, Age, and Cardiovascular Risk. A Complex Relationship.  54:2374-2375. 2009
  • ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease).  54:1364-1405. 2009
  • Regadenoson: A New Myocardial Stress Agent.  54:1123-1130. 2009
  • The Alpha-1D Is the Predominant Alpha-1-Adrenergic Receptor Subtype in Human Epicardial Coronary Arteries.  54:1137-1145. 2009
  • Predictors of Cardiac Rehabilitation Referral in Coronary Artery Disease Patients. Findings From the American Heart Association's Get With The Guidelines Program.  54:515-521. 2009
  • Prediction of Hypertension Improvement After Stenting of Renal Artery Stenosis. Comparative Accuracy of Translesional Pressure Gradients, Intravascular Ultrasound, and Angiography.  53:2363-2371. 2009
  • The Scope of Coronary Heart Disease in Patients With Chronic Kidney Disease.  53:2129-2140. 2009
  • New Insights Into Effects of Verapamil on Reentrant Circuits During Ventricular Fibrillation in In Vivo Pigs.  53:A122-A122. 2009
  • Depression and Cardiovascular Health Care Costs Among Women With Suspected Myocardial Ischemia. Prospective Results From the WISE (Women's Ischemia Syndrome Evaluation) Study.  53:176-183. 2009
  • Skeletal Myoblasts for Cardiac Repair: Act II?.  52:1881-1883. 2008
  • Metallothionein Suppresses Angiotensin II-Induced Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activation, Nitrosative Stress, Apoptosis, and Pathological Remodeling in the Diabetic Heart.  52:655-666. 2008
  • The Effects of Medications on Myocardial Perfusion.  52:401-416. 2008
  • Idiopathic Ventricular Arrhythmias Originating From the Aortic Root. Prevalence, Electrocardiographic and Electrophysiologic Characteristics, and Results of Radiofrequency Catheter Ablation.  52:139-147. 2008
  • Reply.  51:1991. 2008
  • Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease. The TNT (Treating to New Targets) Study.  51:1448-1454. 2008
  • Randomized Controlled Trial of an Implantable Continuous Hemodynamic Monitor in Patients With Advanced Heart Failure. The COMPASS-HF Study.  51:1073-1079. 2008
  • Chemical ablation of subendocardium and Purkinje fibers in dogs causes early termination and activation rate slowing of long duration ventricular fibrillation.  51:A4-A5. 2008
  • Task Force 10: Training in Preventive Cardiovascular Medicine.  51:393-398. 2008
  • Task Force 8: Training in Heart Failure. Endorsed by the Heart Failure Society of America.  51:383-389. 2008
  • Comparison of a Radiofrequency-Based Wireless Pressure Sensor to Swan-Ganz Catheter and Echocardiography for Ambulatory Assessment of Pulmonary Artery Pressure in Heart Failure.  50:2375-2382. 2007
  • Depression, Inflammation, and Incident Cardiovascular Disease in Women With Suspected Coronary Ischemia. The National Heart, Lung, and Blood Institute-Sponsored WISE Study.  50:2044-2050. 2007
  • C-Reactive Protein Gene Polymorphisms, C-Reactive Protein Blood Levels, and Cardiovascular Disease Risk.  50:1115-1122. 2007
  • Two Mechanistic Pathways for Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura. A Report From the SERF-TTP Research Group and the RADAR Project.  50:1138-1143. 2007
  • Post-Heart Transplant Diastolic Dysfunction Is a Risk Factor for Mortality.  50:1064-1069. 2007
  • Preferential Conduction Across the Ventricular Outflow Septum in Ventricular Arrhythmias Originating From the Aortic Sinus Cusp.  50:884-891. 2007
  • Genetic Testing in Cardiovascular Disease.  50:727-737. 2007
  • Recombinant Nematode Anticoagulant Protein c2 in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome. The ANTHEM-TIMI-32 Trial.  49:2398-2407. 2007
  • Early Adult Risk Factor Levels and Subsequent Coronary Artery Calcification. The CARDIA Study.  49:2013-2020. 2007
  • Pretreatment With Intracoronary Enalaprilat Protects Human Myocardium During Percutaneous Coronary Angioplasty.  49:1607-1610. 2007
  • Prevalence and Severity of Left Atrial Edema Detected by Electron Beam Tomography Early After Pulmonary Vein Ablation.  49:1436-1442. 2007
  • Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update.  49:1230-1250. 2007
  • Restitution properties immediately preceding conduction block during ventricular fibrillation.  49:14A-14A. 2007
  • Left Ventricular Eccentric Remodeling and Matrix Loss Are Mediated by Bradykinin and Precede Cardiomyocyte Elongation in Rats With Volume Overload.  49:811-821. 2007
  • Adiponectin and Cardiovascular Disease. Response to Therapeutic Interventions.  49:531-538. 2007
  • Detecting Coronary Artery Disease in Left Bundle Branch Block**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology..  48:1935-1937. 2006
  • Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies..  48:1672-1681. 2006
  • Beta-Blocker Use and Outcomes Among Hospitalized Heart Failure Patients.  47:2462-2469. 2006
  • Effect of Caffeine on Ischemia Detection by Adenosine Single-Photon Emission Computed Tomography Perfusion Imaging.  47:2296-2302. 2006
  • Utility of Impedance Cardiography for the Identification of Short-Term Risk of Clinical Decompensation in Stable Patients With Chronic Heart Failure.  47:2245-2252. 2006
  • Autologous Myoblast Transplantation for Chronic Ischemic Mitral Regurgitation.  47:2086-2093. 2006
  • Menopause and Cardiovascular Risk. Cause or Consequence?* * Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology..  47:1984-1986. 2006
  • Reentry during ventricular fibrillation is less common intramurally than epicardially in swine.  47:4A-4A. 2006
  • Sildenafil enhances angiogenesis after mice Hindlimb ischemia.  47:291A-291A. 2006
  • Three dimensional activation patterns during ventricular fibrillation in swine heart.  47:6A-6A. 2006
  • Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) study.  47:S50-S58. 2006
  • Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Part I: Gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.  47:S4-S20. 2006
  • Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Part II: Gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease.  47:S21-S29. 2006
  • The value of estimated functional capacity in estimating outcome: Results from the NHBLI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.  47:S36-S43. 2006
  • Initial clinical experience with regadenoson, a novel selective A 2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.  46:2069-2075. 2005
  • Intravascular ultrasound for the assessment of an ambiguous left main coronary stenosis [1] (multiple letters).  46:2145-2146. 2005
  • Ultrafiltration: A new approach toward mechanical diuresis in heart failure.  46:2052-2053. 2005
  • Perspectives on dyslipidemia and coronary heart disease in women.  46:1628-1635. 2005
  • The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.  46:770-775. 2005
  • Comparison of human skeletal myoblasts and bone marrow-derived CD133 + progenitors for the repair of infarcted myocardium.  44:458-463. 2004
  • Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: Results from the National Heart, Lung, and Blood Institute women's ischemia syndrome evaluation study.  43:2009-2014. 2004
  • Palliation of allograft vasculopathy with transluminal angioplasty: A decade of experience.  43:1973-1981. 2004
  • Evidence-based guidelines for cardiovascular disease prevention in women.  43:900-921. 2004
  • A Randomized, Double-Blind, Placebo-Controlled Trial of Ad5FGF-4 Gene Therapy and its Effect on Myocardial Perfusion in Patients with Stable Angina.  42:1339-1347. 2003
  • Response to renin-angiotensin system antagonists in hypertensive black subjects [2] (multiple letters).  42:1141-1142. 2003
  • Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans.  42:437-445. 2003
  • Exercise testing in heart failure: Maximal, submaximal, or both?.  42:123-125. 2003
  • Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.  41:1078-1083. 2003
  • Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients.  41:1148-1155. 2003
  • Use of fractional flow reserve versus stress perfusion scintigraphy after unstable angina: Effect on duration of hospitalization, cost, procedural characteristics, and clinical outcome.  41:1115-1121. 2003
  • Effects of intravenous lbutilide on the complexity of activation and the incidence of reentry during ventricular fibrillation in pigs.  41:125A-125A. 2003
  • Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: A report from the NHLBI-sponsored WISE study.  41:413-419. 2003
  • Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: Observations from the ESPRIT trial.  41:386-393. 2003
  • The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease.  40:2006-2012. 2002
  • The effects of acute and chronic amiodarone on activation patterns and defibrillation threshold during ventricular fibrillation in dogs.  40:375-383. 2002
  • Myocardial creatine kinase expression after left ventricular assist device support.  39:1773-1779. 2002
  • Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog.  39:1374-1379. 2002
  • Transmural electrical restitution varies transmurally in the in situ swine heart.  39:108A-108A. 2002
  • Endocardial wave front organization during ventricular fibrillation in humans.  39:109-115. 2002
  • Does the presence of thrombus seen on a coronary angiogram affect the outcome after percutaneous coronary angioplasty? An angiographic trials pool data experience.  38:624-630. 2001
  • Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: Initial human clinical experience.  37:1335-1343. 2001
  • History of anxiety disorders is associated with a decreased likelihood of angiographic coronary artery disease in women with chest pain: The WISE study.  37:780-785. 2001
  • Amiodarone widens excitable gap during ventricular fibrillation.  37:135A-136A. 2001
  • Arterial remodeling influences the development of intimal hyperplasia after stent implantation.  37:70-75. 2001
  • Estrogens, lipids and cardiovascular disease: No easy answers.  37:431-433. 2001
  • Mechanical cardiac support 2000: current applications and future trial design. June 15-16, 2000 Bethesda, Maryland..  37:340-370. 2001
  • Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: The National Registry of Myocardial Infarction 1, 2 and 3.  36:2056-2063. 2000
  • Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy.  36:1913-1919. 2000
  • Weight cycling and high-density lipoprotein cholesterol in women: Evidence of an adverse effect. A report from the NHLBI-sponsored WISE study.  36:1565-1571. 2000
  • Weight cycling and high-density lipoprotein cholesterol in women: evidence of an adverse effect: a report from the NHLBI-sponsored WISE study. Women's Ischemia Syndrome Evaluation Study Group..  36:1565-1571. 2000
  • Signaling and expression for mitochondrial membrane proteins during left ventricular remodeling and contractile failure after myocardial infarction.  36:282-287. 2000
  • Treatment and outcome of myocardial infarction in hospitals with and without invasive capability.  35:371-379. 2000
  • Evolution of ventricular fibrillation in a canine model.  35:150A-150A. 2000
  • Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction - Results of a multicenter, randomized, placebo-controlled trial: The acute myocardial infarction STudy of ADenosine (AMISTAD) trial.  34:1711-1720. 1999
  • Bradykinin-induced preconditioning in patients undergoing coronary angioplasty.  34:639-650. 1999
  • AHA/ACC scientific statement: consensus panel statement. Guide to preventive cardiology for women. American Heart Association/American College of Cardiology..  33:1751-1755. 1999
  • Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study.  33:1469-1475. 1999
  • Dobutamine stress echocardiography in women with chest pain. Pilot phase data from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).  33:1462-1468. 1999
  • The Women's Ischemia Syndrome Evaluation (WISE) study: Protocol design, methodology and feasibility report.  33:1453-1461. 1999
  • Antioxidant vitamins: Sorting out the good and the not so good.  34:1216-1218. 1999
  • Guide to preventive cardiology for women.  33:1751-1755. 1999
  • Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: Results of the platelet aggregation receptor antagonist dose investigation and reperfusion gain in myocardial infarction (PARADIGM) trial.  32:2003-2010. 1998
  • Effect of pravastatin on cardiovascular events in women after myocardial infarction: The Cholesterol and Recurrent Events (CARE) trial.  32:140-146. 1998
  • Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging.  32:57-62. 1998
  • Influence of payor on use of invasive cardiac procedures and patient outcome after myocardial infarction in the United States.  31:1474-1480. 1998
  • Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (Recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: A report from the Second National Registry of Myocardial Infarction (NRMI-2).  31:1240-1245. 1998
  • Correlation between hemodynamic changes and tomographic sestamibi imaging during dipyridamole-induced coronary hyperemia.  31:75-82. 1998
  • Impact of intravascular ultrasound guidance in stent deployment on 6- month restenosis rate: A multicenter, randomized study comparing two strategies - With and without intravascular ultrasound guidance.  32:320-328. 1998
  • Relation between clinical, angiographic and ischemic findings at baseline and ischemia-related adverse outcomes at 1 year in the asymptomatic cardiac ischemia pilot study.  29:1483-1489. 1997
  • The prehospital electrocardiogram in acute myocardial infarction: Is its full potential being realized?.  29:498-505. 1997
  • Ischemic preconditioning during coronary angioplasty [1].  29:469-470. 1997
  • Long-term survival of African Americans in the Coronary Artery Surgery Study (CASS).  29:358-364. 1997
  • The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: Results of the TIMI III registry ECG ancillary study.  30:133-140. 1997
  • Asymptomatic Cardiac Ischemia Pilot (ACIP) study: What clinical implications does it have? [2].  27:1316-1318. 1996
  • A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction.  27:1321-1326. 1996
  • Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation results of a prospective, randomized multicenter trial.  27:1707-1712. 1996
  • Arbutamine stress thallium-201 single-photon emission computed tomography using a computerized closed-loop delivery system. Multicenter trial for evaluation of safety and diagnostic accuracy.  26:1159-1167. 1995
  • Comparison of thallium-201 single-photon emission computed tomography and electrocardiographic response during exercise in patients with normal rest electrocardiographic results.  25:830-836. 1995
  • Lack of association of recreational cocaine and alcohol use with left ventricular mass in young adults. The coronary artery risk development in young adults (CARDIA) study.  25:895-900. 1995
  • Asymptomatic cardiac ischemia pilot (ACIP) study: Effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemia.  26:606-614. 1995
  • Asymptomatic cardiac ischemia pilot (ACIP) study: Impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes.  26:585-593. 1995
  • Asymptomatic cardiac ischemia pilot (ACIP) study: Outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization.  26:594-605. 1995
  • Better functional status in American than Canadian patients with heart disease: An effect of medical care?.  26:1115-1120. 1995
  • Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: A CASS registry study.  25:1000-1009. 1995
  • Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients.  26:120-128. 1995
  • Recurrence of angina after coronary artery bypass surgery: Predictors and prognosis (CASS registry).  26:895-899. 1995
  • Long-term histologic patency after percutaneous transluminal coronary angioplasty is predicted by the creation of a greater lumen area.  24:1229-1235. 1994
  • Myocardial bioenergetic abnormalities in a canine model of left ventricular dysfunction.  23:786-793. 1994
  • A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.  23:993-1003. 1994
  • Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-Week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study.  24:11-20. 1994
  • Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunction.  23:393-400. 1994
  • Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: A report from the registry of studies of left ventricular dysfunction.  23:1410-1420. 1994
  • Safety profile of adenosine stress perfusion imaging: Results from the adenoscan multicenter trial registry.  23:384-389. 1994
  • The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: Design of a randomized clinical trial, baseline data and implications for a long-term outcome trial.  24:1-10. 1994
  • Radiofrequency ablation for treatment of primary atrial tachycardias.  21:901-909. 1993
  • Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris.  21:1605-1611. 1993
  • Identification of extensive coronary artery disease in women by exercise single-photon emission computed tomographic (SPECT) thallium imaging.  21:1305-1311. 1993
  • Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.  22:665-670. 1993
  • Task force 4: Function of the heart trnsplant recipient.  22:31-41. 1993
  • Task force 6: Future developments.  22:54-64. 1993
  • Effect of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the coronary artery surgery study (CASS): 10-Year follow-up.  20:287-294. 1992
  • Intracoronary ethanol ablation for the treatment of recurrent sustained ventricular tachycardia.  19:159-168. 1992
  • Nonsurgical closure of femoral pseudoaneurysms complicating cardiac catheterization and percutaneous transluminal coronary angioplasty.  20:610-615. 1992
  • Prognostic significance of ventricular premature depolarizations measured 1 year after myocardial infraction in patient with early postinfarction asymptomatic ventricular arrhythmia.  20:259-264. 1992
  • Tomographic myocardial perfusion imaging with technetium-99m teboroxime during adenosine-induced coronary hyperemia: Correlation with thallium-201 imaging.  19:307-312. 1992
  • Usefulness and limitations of transesophageal echocardiography in the assessment of proximal coronary artery stenosis.  19:572-580. 1992
  • Vascular pathology of balloon-expandable flexible coil stents in humans.  19:372-381. 1992
  • A prospective evaluation of intracoronary ethanol ablation of the atrioventricular conduction system.  17:1634-1640. 1991
  • Amplitude information from Doppler color flow mapping systems: A preliminary study of the power mode.  18:997-1003. 1991
  • Cardioplegia by way of the coronary sinus for valvular and coronary surgery.  18:628-636. 1991
  • Intermediate septal accessory pathways: Electrocardiographic characteristics, electrophysiologic observations and their surgical implications.  17:1570-1578. 1991
  • Relation between functional and anatomic descriptors of coronary artery disease.  17:363-364. 1991
  • Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction.  17:1007-1016. 1991
  • Single photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: Correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography.  16:1375-1383. 1990
  • The thrombolysis in myocardial infarction (TIMI) Trial Phase II: Additional information and perspectives.  15:1188-1192. 1990
  • Transesophageal Doppler color flow mapping assessment of atrial septal defect.  16:1010-1016. 1990
  • Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: Analysis of 461 patients.  14:1477-1486. 1989
  • Can two-dimensional echocardiography and Doppler color flow mapping identify the need for tricuspid valve repair?.  14:1266-1274. 1989
  • Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.  13:786-793. 1989
  • Color doppler diagnosis of left ventricular pseudoaneurysm.  13:512. 1989
  • Comparison of endocardial and epicardial programmed stimulation for the induction of ventricular tachycardia.  13:1608-1612. 1989
  • Coronary artery to right ventricle fistula in heart transplant recipients: A complication of endomyocardial biopsy.  14:258-261. 1989
  • Doppler color flow mapping in the evaluation of prosthetic mitral and aortic valve function.  13:1561-1571. 1989
  • Relation between myocardial thallium-201 kinetics during exercise and quantitative coronary angiography in patients with one vessel coronary artery disease.  13:1301-1308. 1989
  • Reproducibility of two-dimensional exercise echocardiography.  14:923-928. 1989
  • The value of cine nuclear magnetic resonance imaging for assessing regional ventricular function.  14:1721-1729. 1989
  • Color-guided Doppler echocardiographic assessment of aortic valve stenosis.  12:441-449. 1988
  • Exercise training after anterior Q wave myocardial infarction: Harmful or beneficial.  12:373-374. 1988
  • Intraoperative echocardiography: Who monitors the flood once the flood gates are opened?.  11:1362-1364. 1988
  • Alpha-myosin heavy chain isoform and atrial size in patients with various types of mitral valve dysfunction: A quantitative study.  9:1024-1030. 1987
  • Evaluation of aortic insufficiency by Doppler color flow mapping.  9:952-959. 1987
  • The thrombolysis in myocardial infarction (TIMI) phase II pilot study: Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty.  10:51B-64B. 1987
  • Pathogenesis of ventricular hypertrophy..  5:57B-65B. 1985
  • Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function.  5:1036-1045. 1985
  • Morphologie substrates of sudden death: Questions and answers.  5:79B-80B. 1985
  • Pathogenesis of ventricular hypertrophy.  5:57B-65B. 1985
  • The plights of the invasive treatment of ischemic heart disease.  5:158-167. 1985
  • Ejection fraction determination without planimetry by two-dimensional echocardiography: A new method.  1:1471-1478. 1983
  • International Standard Serial Number (issn)

  • 0735-1097
  • Electronic International Standard Serial Number (eissn)

  • 1558-3597